Literature DB >> 9409699

Influence of a GABA(B) receptor antagonist on the sleep-waking cycle in the rat.

P Gauthier1, C Arnaud, G Gandolfo, C Gottesmann.   

Abstract

The influence of CGP 35348 (a GABA(B) receptor antagonist) on the sleep-waking cycle was studied in rats. The animals were injected i.p. at the beginning of the light period and the data expressed by 2-h periods and total duration (6 h). At 100 mg/kg, slow-wave sleep (SWS) was decreased during the 6-h recording with a peculiar decrease during the first 2 h. SWS was subdivided into three stages: slow-waves; spindles occurring as SWS deepens; and intermediate stage appearing prior to paradoxical sleep (PS). Only the slow-wave stage and intermediate stage were decreased. Waking was increased during the 6-h recording. It was subdivided into waking with hippocampal theta rhythm (psychomotor active waking) and waking without theta activity (quiet waking). Both were increased during the first 2 h. However, quiet waking was increased throughout the recording duration. At 300 mg/kg, SWS was decreased during the three 2-h periods. This decrease was principally related to a decrease of the slow-wave stage. PS was increased over the 6-h recording with a marked increase during the second 2-h period. Consequently, under the influence of the GABA(B) receptor antagonist, the SWS was decreased at the expense of behavioral stages with cortical low-voltage activity (waking and PS). GABAergic neurons are present in the mesopontine structures responsible for these two stages. We can conclude that endogenous GABA acting at the GABA(B) receptor level participates in the regulation of waking and PS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409699     DOI: 10.1016/s0006-8993(97)00643-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

2.  Selective loss of GABA(B) receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture.

Authors:  Taizo Matsuki; Mika Nomiyama; Hitomi Takahira; Noriko Hirashima; Satoshi Kunita; Satoru Takahashi; Ken-ichi Yagami; Thomas S Kilduff; Bernhard Bettler; Masashi Yanagisawa; Takeshi Sakurai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

3.  Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial.

Authors:  Dario A Dornbierer; Diego M Baur; Benjamin Stucky; Boris B Quednow; Thomas Kraemer; Erich Seifritz; Oliver G Bosch; Hans-Peter Landolt
Journal:  Neuropsychopharmacology       Date:  2019-04-08       Impact factor: 7.853

4.  The efficacy study on si ni san freeze-dried powder on sleep phase in insomniac and normal rats.

Authors:  Yuefeng Li; Angguo Liu; Ying Wang; Xingke Yan
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

5.  Sleep, Narcolepsy, and Sodium Oxybate.

Authors:  Mortimer Mamelak
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.